NO20060554L - Fremgangsmate for fremstilling av C1-C15-fragmenter av epotiloner og derivater derav - Google Patents

Fremgangsmate for fremstilling av C1-C15-fragmenter av epotiloner og derivater derav

Info

Publication number
NO20060554L
NO20060554L NO20060554A NO20060554A NO20060554L NO 20060554 L NO20060554 L NO 20060554L NO 20060554 A NO20060554 A NO 20060554A NO 20060554 A NO20060554 A NO 20060554A NO 20060554 L NO20060554 L NO 20060554L
Authority
NO
Norway
Prior art keywords
fragments
epothilones
derivatives
fragment
preparing
Prior art date
Application number
NO20060554A
Other languages
English (en)
Norwegian (no)
Inventor
Ulrich Klar
Werner Skuballa
Wolfgang Schwede
Bernd Buchmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20060554L publication Critical patent/NO20060554L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/17Saturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
NO20060554A 2003-07-03 2006-02-02 Fremgangsmate for fremstilling av C1-C15-fragmenter av epotiloner og derivater derav NO20060554L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10331004A DE10331004A1 (de) 2003-07-03 2003-07-03 Verfahren für die Herstellung von C1-C15-Fragmenten von Epothilonen und deren Derivaten
PCT/EP2004/006685 WO2005003071A1 (de) 2003-07-03 2004-06-19 Verfahren für die herstellung von c1-c15-fragmenten von epothilonen und deren derivaten

Publications (1)

Publication Number Publication Date
NO20060554L true NO20060554L (no) 2006-04-03

Family

ID=33559999

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060554A NO20060554L (no) 2003-07-03 2006-02-02 Fremgangsmate for fremstilling av C1-C15-fragmenter av epotiloner og derivater derav

Country Status (17)

Country Link
US (1) US20070142675A1 (ja)
EP (1) EP1641734A1 (ja)
JP (1) JP2009513498A (ja)
KR (1) KR20060030102A (ja)
CN (2) CN101293819A (ja)
AU (1) AU2004254200A1 (ja)
BR (1) BRPI0412179A (ja)
CA (1) CA2531078A1 (ja)
CR (1) CR8128A (ja)
DE (1) DE10331004A1 (ja)
EA (1) EA200600149A1 (ja)
EC (1) ECSP066344A (ja)
IL (1) IL172936A0 (ja)
MX (1) MXPA06000172A (ja)
NO (1) NO20060554L (ja)
RS (1) RS20050973A (ja)
WO (1) WO2005003071A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8026081B2 (en) 2006-03-28 2011-09-27 Sumitomo Chemical Company, Limited Method of producing optically active (S)-7-hydroxy-6-methylheptan-2-one and precursor thereof
CN101519404B (zh) * 2008-02-29 2016-01-20 唐莉 15环噻酮衍生物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969145A (en) * 1996-08-30 1999-10-19 Novartis Ag Process for the production of epothilones and intermediate products within the process
US6204388B1 (en) * 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
DE69734362T2 (de) * 1996-12-03 2006-07-20 Sloan-Kettering Institute For Cancer Research Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
AU9340998A (en) * 1997-08-09 1999-03-01 Schering Aktiengesellschaft New epothilone derivatives, method for producing same and their pharmaceutical use
US7125893B1 (en) * 1999-04-30 2006-10-24 Schering Ag 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
US6518421B1 (en) * 2000-03-20 2003-02-11 Bristol-Myers Squibb Company Process for the preparation of epothilone analogs
US6593115B2 (en) * 2000-03-24 2003-07-15 Bristol-Myers Squibb Co. Preparation of epothilone intermediates
US6933385B2 (en) * 2001-08-03 2005-08-23 Schering Ag Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use
WO2003022844A2 (en) * 2001-09-06 2003-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones intermediates thereto and analogues thereof
DE10164592A1 (de) * 2001-12-21 2003-07-03 Schering Ag C1-C6-Epothilon-Fragmente und Verfahren für die Herstellung von C1-C6-Fragmenten von Epothilonen und deren Derivaten
EP1340498A1 (en) * 2002-03-01 2003-09-03 Schering Aktiengesellschaft Use of epothilones in the treatment of brain diseases associated with proliferative processes

Also Published As

Publication number Publication date
JP2009513498A (ja) 2009-04-02
MXPA06000172A (es) 2006-04-27
CR8128A (es) 2006-05-29
BRPI0412179A (pt) 2006-08-22
KR20060030102A (ko) 2006-04-07
DE10331004A1 (de) 2005-02-24
AU2004254200A1 (en) 2005-01-13
WO2005003071A1 (de) 2005-01-13
EA200600149A1 (ru) 2006-08-25
EP1641734A1 (de) 2006-04-05
IL172936A0 (en) 2006-06-11
ECSP066344A (es) 2006-08-30
RS20050973A (en) 2007-09-21
CN1816514A (zh) 2006-08-09
CN101293819A (zh) 2008-10-29
US20070142675A1 (en) 2007-06-21
CA2531078A1 (en) 2005-01-13
CN100480225C (zh) 2009-04-22

Similar Documents

Publication Publication Date Title
EA200700852A1 (ru) Новый способ получения пищевых продуктов
NO20093402L (no) Framgangsmate for syntetisering av camptothesin relaterte forbindelser
NO20060544L (no) Enzymatiske prosesser for produksjon av 4-substituerte 3-hydroksysmorsyrederivater og naerliggende cyano, hydroksy substituerte karboksylsyre estere
WO2008076747A3 (en) Processes of producing fermentation products
DE602004024964D1 (de) Verfahren zur herstellung von alkohol
EA201200954A1 (ru) Способ получения полугидрата гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1н-3-бензазепина, фармацевтическая композиция на его основе и его применение
EP1705251A4 (en) PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY RNA INHIBITION OF FUNCTION OF $ G (A) 1,6-FUCOSYLTRANSFERASE
RS20050235A (en) Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
HUP0103291A2 (hu) Eljárás citalopram előállítására
WO2006061215A3 (de) 2-alkyl-cycloalk(en)yl-carboxamide
UA94080C2 (ru) Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний
WO2005048954A3 (en) Continuous process for producing hydroxyazapirones by oxidation
NO20060554L (no) Fremgangsmate for fremstilling av C1-C15-fragmenter av epotiloner og derivater derav
EA200801348A1 (ru) Способ получения промежуточных соединений хлорамфеникола или его аналогов
DE602004003037D1 (de) Verfahren und zwischenprodukte für die herstellung von emtricitabin
NO20065157L (no) Biotransformasjon av colchicinoidforbindelser
FR2826652B1 (fr) Procede de preparation de composes type azoique.
WO2008089005A3 (en) Renin inhibitors
WO2005063731A3 (en) Production of dihydronepetalactone by reduction of nepetalic acid
NO20064352L (no) Fremgangsmate for fremstilling av pyrrolidinoksimer
WO2008081817A1 (ja) α-ガラクトオリゴ糖の製造方法
NO20076139L (no) Fremgangsmate for a fremstille blekeaktivatorer
WO2008006720A3 (en) Crystalline nemorubicin hydrochloride
HUP0400525A2 (hu) Eljárás benzol-dimetanol vegyület előállítására

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application